Intera Atlas
Run match
Sites / Meridian Clinical Research
Is this you?

Request access for Meridian Clinical Research with your @meridianclinicalresearch.flywheelsites.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Meridian Clinical Research

Unclaimed profile

Site Network · Omaha, NE · ~35+ sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 9Lift (cardio sample) 0.36Recruit soph 0.14
Quality Scorecard (1–100)
Overall83Recruit69Ops85Sponsor90Ther91

Performance (observed)

Historical trials
572
Completed
347
Terminated/Withdrawn
45
Completion rate
89%
Active now
161
Phase 2
198
Phase 3
317
Realized enrollment
999,786
First study year
1999
Years active
27
Match confidence
high
Enrollment velocity (inf)
37,029

Therapeutic

Areas
Multi-specialty: vaccines (high-volume), allergy, cardiology, gastroenterology, immunology, metabolic, neurology, dermatology, infectious disease, women's health
Specialties
Multi-specialty; vaccines, diabetes, allergies, chronic disease, infectious disease
Breadth (conditions)
1,169
States
25+ US states (North America)

Recruitment (web observed)

Advertises recruitment
Yes
SEO
Limited; site accessibility issues
Capability notes
80,000+ participants enrolled; 3,400+ studies conducted; 90+ principal investigators; vaccine trials specialist; high-volume enrollment expertise; centralized operations

Relationships

Sponsors
National Cancer Institute (NCI); Pfizer; SWOG Cancer Research Network; Alliance for Clinical Trials in Oncology; ModernaTX, Inc.; ECOG-ACRIN Cancer Research Group
CROs
Acrotech Biopharma Inc.; Covance; Croma-Pharma GmbH; ICON Clinical Research; IQVIA Pty Ltd; Medpace, Inc.
Owner / parent
Acquired by Velocity Clinical Research (Dec 2022); formerly independent

Capacity & people

Investigators
—
Coordinators
—
CEO
Nicole Osborn (Founder)
VP Clinical Ops
Kathy Stoddard, RN, CCRC (Chief Operating Officer)
VP Site Ops
Laura Falcone, APRN (President)
VP Recruitment
Andrew Kimball (Chief Commercial Officer)

Tech & DCT

Uses AI
Yes
Builds tech
Vendors (Todata partnership for analytics)
Tech stack
CTMS (Todata analytics integration mentioned; SiteGrades business intelligence tool)
Recruiting visible
Y

Notes

Exceptional Intera fit: 35+ sites, 25+ states, 90+ PIs, 3,400+ studies conducted, 80K+ enrollments. Multi-specialty (cardiometabolic, vaccines, neuro). Founder-led (Nicole Osborn since 1999). Vaccine specialist (high-volume). Now part of Velocity Clinical Research post-acquisition. Uses business intelligence analytics. Innovation-focused. Recruitment-constrained enrollment engine. [Validated: 3 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.42Liftability 0.36Overall83

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.